Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? A Protagonist View From the SPRINT Trial (Systolic Blood Pressure Intervention Trial).
From Department of Medicine, Division of Cardiovascular Disease, Vascular Biology and Hypertension Program, The University of Alabama at Birmingham (S.O.); and Department of Medicine, Division of Preventive Medicine, The University of Alabama at Birmingham (C.E.L.). soparil@uabmc.edu.
Suzanne
S
Oparil
From Department of Medicine, Division of Cardiovascular Disease, Vascular Biology and Hypertension Program, The University of Alabama at Birmingham (S.O.); and Department of Medicine, Division of Preventive Medicine, The University of Alabama at Birmingham (C.E.L.).
Cora E
CE
Lewis
D000368:Aged; D001794:Blood Pressure; D018572:Disease-Free Survival; D006801:Humans; D006973:Hypertension / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D008875:Middle Aged; D051436:Renal Insufficiency, Chronic / Q000401:mortality / Q000469:parasitology / Q000628:therapy; D012307:Risk Factors; D012737:Sex Factors; D015996:Survival Rate
blood pressure; blood pressure measurement/monitoring; clinical trial; high blood pressure; hypertension